Polymannuronic Acid Prebiotic plus Lacticaseibacillus Rhamnosus GG Probiotic as a Novel Synbiotic Promoted Their Separate Neuroprotection against Parkinson’s Disease

Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634 · see citing works

Pathological roles of MAPK signaling pathways in human diseases

Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472 · see citing works

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Probiotics, Prebiotics, and Synbiotics

de Vrese, M., & Schrezenmeir, J. (2008) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2008_097 · Cited by 1,034 · see citing works

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Seppi, K., Chaudhuri, К. R., Coelho, M. M., Fox, S. H., Katzenschlager, R., Perez‐Lloret, S., Weintraub, D. A., & Sampaio, C. (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,013 · see citing works

GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration

Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820 · see citing works

Probiotic species in the modulation of gut microbiota: An overview

Azad, M. A. K., Sarker, M., Li, T., & Yin, J. (2018) · BioMed Research International · doi:10.1155/2018/9478630 · Cited by 803 · see citing works

Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health

Parker, A., Fonseca, S., & Carding, S. R. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1638722 · Cited by 722 · see citing works

Microbiota restoration: natural and supplemented recovery of human microbial communities

Reid, G., Younes, J. A., van der Mei, H. C., Gloor, G. B., Knight, R. D., & Busscher, H. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2473 · Cited by 585 · see citing works

Specific role of tight junction proteins claudin-5, occludin and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult

Jiao, H., Wang, Z., Liu, Y., Wang, P., & Xue, Y. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9496-4 · Cited by 411 · see citing works

Gut microbiota in neurodegenerative disorders

Sarkar, S. R., & Banerjee, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.01.004 · Cited by 319 · see citing works

A review of dose-responses of probiotics in human studies

Ouwehand, A. C. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0140 · Cited by 233 · see citing works

Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity

Srivastav, S., Neupane, S., Bhurtel, S., Katila, N., Maharjan, S., Choi, H., Hong, J. T., & Choi, D.-Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.021 · Cited by 212 · see citing works

The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies

Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203 · see citing works

Constipation in parkinson's disease: Objective assessment and response to psyllium

Ashraf, W., Pfeiffer, R. F., Park, F. L., Lof, J., & Quigley, E. (1997) · Movement Disorders · doi:10.1002/mds.870120617 · Cited by 200 · see citing works

Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?

Breen, D. P., Halliday, G. M., & Lang, A. E. (2019) · Movement Disorders · doi:10.1002/mds.27556 · Cited by 193 · see citing works

Probiotics Alleviate the progressive deterioration of motor functions in a mouse model of Parkinson’s disease

Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10040206 · Cited by 174 · see citing works

Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

Lai, F., Jiang, R., Xie, W., Liu, X., Tang, Y., Xiao, H., Gao, J., Jia, Y., & Bai, Q. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2620-x · Cited by 169 · see citing works

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease

Yang, D., Zhao, D., Ali Shah, S. Z., Wu, W., Lai, M., Zhang, X., Li, J., Guan, Z., Zhao, H., Li, W., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01155 · Cited by 162 · see citing works

Effects of the probiotic formulation SLAB51 in <i>in vitro</i> and <i>in vivo</i> Parkinson’s disease models

Castelli, V., d’Angelo, M., Lombardi, F., Alfonsetti, M., Antonosante, A., Catanesi, M., Benedetti, E., Palumbo, P., Cifone, M. G., Giordano, A., et al. (2020) · Aging · doi:10.18632/aging.102927 · Cited by 162 · see citing works

Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease

Liao, J.-F., Cheng, Y.-F., You, S.-T., Kuo, W.-C., Huang, C.-W., Chiou, J.-J., Hsu, C.-C., Hsieh-Li, H.-M., Wang, S., & Tsai, Y.-C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.036 · Cited by 159 · see citing works

Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson’s disease

Sun, M., Kong, L., Wang, X., Lu, X.-G., Gao, Q., & Geller, A. I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.072 · Cited by 154 · see citing works

Probiotics for Parkinson’s Disease

Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 152 · see citing works

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis

Labus, J. S., Osadchiy, V., Hsiao, E. Y., Tap, J., Derrien, M., Gupta, A., Tillisch, K., Nevé, B. L., Grinsvall, C., Ljungberg, M., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0656-z · Cited by 136 · see citing works

Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders

Israelyan, N., & Margolis, K. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.020 · Cited by 122 · see citing works

Clinical and Pharmacokinetic Effects of a Diet Rich in Insoluble Fiber on Parkinson Disease

Astarloa, R., Mena, M. A., Sánchez, V., Vega, L., & de Yébenes, J. G. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199210000-00004 · Cited by 121 · see citing works

GDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine

Cass, W. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08132.1996 · Cited by 99 · see citing works

Management of constipation in patients with Parkinson’s disease

Carrasco, A. J. P., Timmermann, L., & Pedrosa, D. J. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0042-8 · Cited by 84 · see citing works

Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease

Cantu-Jungles, T. M., Rasmussen, H. E., & Hamaker, B. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00663 · Cited by 84 · see citing works

Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease

Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 77 · see citing works

Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model

Dong, X.-L., Wang, X., Liu, F., Liu, X., Du, Z.-R., Li, R. W., Xue, C.-H., Wong, K.-H., Wong, W.-T., Zhao, Q., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.180 · Cited by 75 · see citing works

Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

Hébert, G. A., Arsaut, J., Dantzer, R., & Demotes‐Mainard, J. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00832-2 · Cited by 69 · see citing works

Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease

Ciesielska, A., Joniec‐Maciejak, I., Przybyłkowski, A. M., Gromadzka, G., Iwona, Członkowska, A., & Członkowski, A. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1461 · Cited by 68 · see citing works

Targeting the Microbiota in Pharmacology of Psychiatric Disorders

Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104856 · Cited by 67 · see citing works

Comparative study on antioxidative and macrophage-stimulating activities of polyguluronic acid (PG) and polymannuronic acid (PM) prepared from alginate

Ueno, M., Hiroki, T., Takeshita, S., Jiang, Z., Kim, D., Yamaguchi, K., & Oda, T. (2012) · Carbohydrate Research · doi:10.1016/j.carres.2012.02.005 · Cited by 56 · see citing works

Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson’s Disease

Xie, C., & Prasad, A. A. (2020) · Microorganisms · doi:10.3390/microorganisms8111661 · Cited by 56 · see citing works

Polymannuronic acid ameliorated obesity and inflammation associated with a high-fat and high-sucrose diet by modulating the gut microbiome in a murine model

Liu, F., Wang, X., Shi, H., Wang, Y., Xue, C., & Tang, Q. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000964 · Cited by 48 · see citing works

A nutritional approach to microbiota in Parkinson’s disease

Uyar, G. Ö., & Yıldıran, H. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.19-002 · Cited by 45 · see citing works

Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?

van Laar, T., Boertien, J. M., & Herranz, A. H. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191802 · Cited by 42 · see citing works

2015 Update on Parkinson disease

Fernandez, H. H. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82gr.15004 · Cited by 37 · see citing works

Preparation, characterization and antioxidant activities of polymannuronic acid phosphate, H-phosphonate and sulfate

Li, Q., Li, C., Yang, C., Liu, C., Yu, G., & Guan, H. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.09.012 · Cited by 34 · see citing works

Bax, Bcl-2, and cyclin expression and apoptosis in rat substantia nigra during development

Groc, L., Bezin, L., Jiang, H., Jackson, T. S., & Levine, R. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01897-3 · Cited by 30 · see citing works

Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease Mice Model

Liu, X., Du, Z.-R., Wang, X., Luk, K.-H., Chan, C.-H., Cao, X., Zhao, Q. S., Zhao, F., Wong, W., Wong, K., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.649627 · Cited by 22 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications

Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., Barba, C. D., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 422 · see citing works

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies

Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177 · see citing works

Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders

Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175 · see citing works

The gut microbiota–brain axis in neurological disorders

You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 107 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic

Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 78 · see citing works

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease

Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76 · see citing works

Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation

Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 58 · see citing works

Neuroprotective Effects of Lactobacillus plantarum PS128 in a Mouse Model of Parkinson’s Disease: The Role of Gut Microbiota and MicroRNAs

Lee, Y. Z., Cheng, S.-H., Chang, M.-Y., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076794 · Cited by 54 · see citing works

Synbiotic therapy with Clostridium sporogenes and xylan promotes gut-derived indole-3-propionic acid and improves cognitive impairments in an Alzheimer's disease mouse model

Li, L., Yang, C., Jia, M., Wang, Y., Zhao, Y., Li, Q., Gong, J., He, Y., Xu, K., Liu, X., et al. (2024) · Food & Function · doi:10.1039/d4fo00886c · Cited by 51 · see citing works

The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System—A Systematic Review

Skowron, K., Budzyńska, A., Wiktorczyk-Kapischke, N., Chomacka, K., Grudlewska‐Buda, K., Wilk, M., Wałecka-Zacharska, E., Andrzejewska, M., & Gospodarek-Komkowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147820 · Cited by 47 · see citing works

Lactic Acid Bacteria (LAB) and Neuroprotection, What Is New? An Up-To-Date Systematic Review

Mutalib, N. A., Mohamad, S. A. S., Jusril, N. A., Hasbullah, N. I., Amin, M. C. I. M., & Ismail, N. H. (2023) · Pharmaceuticals · doi:10.3390/ph16050712 · Cited by 52 · see citing works

Stachyose in combination with L. rhamnosus GG ameliorates acute hypobaric hypoxia-induced intestinal barrier dysfunction through alleviating inflammatory response and oxidative stress

Ren, D., Ding, M., Su, J., Ye, J., He, X., Zhang, Y., & Shang, X. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.009 · Cited by 40 · see citing works

Role of dietary fiber and short-chain fatty acids in preventing neurodegenerative diseases through the gut-brain axis

Choe, U. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106870 · Cited by 45 · see citing works

Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate

Avagliano, C., Coretti, L., Lama, A., Pirozzi, C., Caro, C. D., Biase, D. D., Turco, L., Mollica, M. P., Paciello, O., Calignano, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126367 · Cited by 39 · see citing works

The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial

Mehrabani, S., Khorvash, F., Heidari, Z., Ebrahimi, M. T., & Amani, R. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105397 · Cited by 38 · see citing works

Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature

Beltrán-Velasco, A. I., Reiriz, M., Uceda, S., & Echeverry‐Alzate, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053010 · Cited by 38 · see citing works

Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights

Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 39 · see citing works

A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease

Aktaş, B., Aslım, B., & Özdemir, D. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-65061-w · Cited by 37 · see citing works

Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease

Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Food & Function · doi:10.1039/d2fo03825k · Cited by 32 · see citing works

Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements

Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Saharan, B. S., Harshita, Duhan, J. S., & Gökşen, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300461 · Cited by 30 · see citing works

Parkinson’s disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons

Yadav, S., & Raj, R. G. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.003 · Cited by 24 · see citing works

Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain

Shahbazi, A., Sepehrinezhad, A., Vahdani, E., Jamali, R., Ghasempour, M., Massoudian, S., Negah, S. S., & Larsen, F. S. (2023) · Biomedicines · doi:10.3390/biomedicines11051272 · Cited by 24 · see citing works

The link between the gut microbiome, inflammation, and Parkinson’s disease

Nie, S., & Ge, Y. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12789-6 · Cited by 23 · see citing works

Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS

Lee, A., Henderson, R. D., Aylward, J., & McCombe, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031871 · Cited by 23 · see citing works

Indole lactic acid derived from Akkermansia muciniphila activates the aryl hydrocarbon receptor to inhibit ferroptosis in ischemic stroke

Wang, J., Peng, Y., Liu, Y., Lian, Z., Cai, Z., Chen, Y., He, H., Yang, M., & Zhao, J. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.020 · Cited by 22 · see citing works

Selenium Forms and Dosages Determined Their Biological Actions in Mouse Models of Parkinson’s Disease

Sun, C., Du, Z., Liu, X., Ye, Y., Zhou, S., Li, C., Cao, X., Zhao, Q. S., Wong, K., Chen, W., et al. (2022) · Nutrients · doi:10.3390/nu15010011 · Cited by 22 · see citing works

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works

Microecologics and Exercise: Targeting the Microbiota–Gut–Brain Axis for Central Nervous System Disease Intervention

Peng, Z., Hou, T., Yang, K., Zhang, J., Mao, Y.-H., & Hou, X. (2025) · Nutrients · doi:10.3390/nu17111769 · Cited by 19 · see citing works

Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance

Tao, W., Zhang, Y., Wang, B., Nie, S., Li, F., Xiao, J., & Wu, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.023 · Cited by 19 · see citing works

The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review

Panaitescu, P.-Ș., Răzniceanu, V., Mocrei-Rebrean, Ș.-M., Neculicioiu, V. S., Dragoș, H.-M., Costache, C. A., & Filip, G. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050244 · Cited by 18 · see citing works

Implications of Butyrate Signaling Pathways on the Motor Symptomatology of Parkinson’s Disease and Neuroprotective Effects—Therapeutic Approaches: A Systematic Review

Missiego-Beltrán, J., Olalla-Álvarez, E. M., González-Brugera, A., & Beltrán-Velasco, A. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168998 · Cited by 18 · see citing works

The Role of an Altered Gut Microbiome in Parkinson’s Disease: A Narrative Review

Hashish, S. A., & Salama, M. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3020030 · Cited by 17 · see citing works

Low and high doses of oral maslinic acid protect against Parkinson’s disease via distinct gut microbiota-related mechanisms

Cao, X., Du, Z.-R., Liu, X., Wang, X., Li, C., Zhou, S.-N., Liu, J.-R., Xu, P.-Y., Ye, J.-L., Zhao, Q., et al. (2023) · Biomedicine &amp; Pharmacotherapy · doi:10.1016/j.biopha.2023.115100 · Cited by 15 · see citing works

Corinthian Currants Supplementation Restores Serum Polar Phenolic Compounds, Reduces IL-1beta, and Exerts Beneficial Effects on Gut Microbiota in the Streptozotocin-Induced Type-1 Diabetic Rat

Kompoura, V., Prapa, I., Vasilakopoulou, P. B., Mitropoulou, G., Nelios, G., Balafas, E., Kostomitsopoulos, N. G., Chiou, A., Karathanos, V. Τ., Bezirtzoglou, E., et al. (2023) · Metabolites · doi:10.3390/metabo13030415 · Cited by 14 · see citing works

Lactobacillus rhamnosus GG improves cognitive impairments in mice with sepsis

Wang, L., Zhao, R., Li, X., Shao, P. L., Xie, J., Su, X., Xu, S., Huang, Y., & Hu, S. (2024) · PeerJ · doi:10.7717/peerj.17427 · Cited by 18 · see citing works

Lactobacillus rhamnosus GG attenuates depression‐like behaviour and cognitive deficits in chronic ethanol exposure mice by down‐regulating systemic inflammatory factors

Pan, X., Guo, A., Guan, K., Chen, C., Xu, S., Tang, Y., Li, X., & Huang, Z. (2024) · Addiction Biology · doi:10.1111/adb.13445 · Cited by 13 · see citing works

Gut-directed therapy in Parkinson’s disease

Benvenuti, L., Salvo, C. D., Bellini, G., Seguella, L., Rettura, F., Esposito, G., Antonioli, L., Ceravolo, R., Bernardini, N., Pellegrini, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407925 · Cited by 13 · see citing works

Microbiome Engineering for Biotherapeutic in Alzheimer’s Disease Through the Gut–Brain Axis: Potentials and Limitations

Renesteen, E., Boyajian, J. L., Islam, P., Kassab, A., Abosalha, A. K., Makhlouf, S., Santos, M., Chen, H., Shum-Tim, C., & Prakash, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115351 · Cited by 11 · see citing works

The role of the gut microbiota in neuropsychiatric disorders and therapy

Zhang, F., Ding, K., Zhang, L., Liu, D., Dong, X., Wang, M., Zhou, F.-L., Sun, Y., Zhang, W., Yu, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102894 · Cited by 11 · see citing works

Gut-oriented disease modifying therapy for Parkinson's disease

Lin, C., Lai, H., & Wu, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.09.010 · Cited by 11 · see citing works

Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective

Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 10 · see citing works

Short-Chain Fatty Acids Alleviate Perioperative Neurocognitive Disorders Through BDNF/PI3K/Akt Pathway in Middle-Aged Rats

Liu, X., Cui, J., Tan, X., Yu, Y., Niu, J., & Wang, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04964-9 · Cited by 9 · see citing works

Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics

Hor, J. W., Toh, T. S., Lim, S., & Tan, A. H. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240172 · Cited by 9 · see citing works

Intestinal microbiota distribution and changes in different stages of Parkinson's disease: A meta-analysis, bioinformatics analysis and in vivo simulation

Jiang, T., Wang, Y., Fan, W., Lu, Y., Zhang, G., Li, J., Ma, R., Liu, M., & Shi, J. (2025) · BioScience Trends · doi:10.5582/bst.2024.01352 · Cited by 8 · see citing works

Brazilin-Rich Extract from Caesalpinia sappan L. Attenuated the Motor Deficits and Neurodegeneration in MPTP/p-Induced Parkinson’s Disease Mice by Regulating Gut Microbiota and Inhibiting Inflammatory Responses

Gao, W., Wu, X., Wang, Y., Lu, F., & Liu, F. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00679 · Cited by 8 · see citing works

Synergistic protective effects of probiotics Lactiplantibacillus plantarum S58 and prebiotics Qingke β-glucan on dextran sulfate sodium-induced cognitive deficits in colitis mice: A study of microbial-gut-brain axis modulation

Jiang, Y., Zhao, J., Li, Y., Xin, W., Song, J.-J., Chen, X.-Y., Wang, C., & Suo, H. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106266 · Cited by 7 · see citing works

Lacticaseibacillus casei IDCC 3451 alleviates cognitive and behavioral functions by reshaping the gut microbiome and regulating intestinal barrier integrity in chronic stress animal models

Kang, A., Eor, J. Y., Lee, J., Kwak, M., Lee, D. J., Seo, E., Lee, W. J., Son, S.-H., Song, M., Kim, J.-M., et al. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101051 · Cited by 9 · see citing works

Research progress regarding physiological functions of probiotics and techniques to enhance their stress resistance: a review

Luo, W. F., Yang, L., Ding, Y., Zhuang, Y., Sun, L., Gu, Y., & Fan, X. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2496667 · Cited by 7 · see citing works

The role of gut-derived short-chain fatty acids in Parkinson's disease

Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9 · see citing works

Faecalibacterium prausnitzii, depleted in the Parkinson’s disease microbiome, improves motor deficits in α-synuclein overexpressing mice

Moiseyenko, A., Antonello, G., Schonhoff, A. M., Boktor, J. C., Long, K., Dirks, B., Oguienko, A. D., Winnett, A. V., Simpson, P., Daeizadeh, D., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01287-x · Cited by 7 · see citing works

Bidirectional communication of the gut-brain axis: new findings in Parkinson’s disease and inflammatory bowel disease

Zhang, W., Jiao, Y., Wen, H., Bin, X., Xuefei, W., Lan, J., & Liuyin, Z. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1407241 · Cited by 6 · see citing works

Probiotic: A Gut Microbiota-Based Therapeutic Approaches for the Treatment of Parkinson’s Disease

Rout, M., Prusty, S. K., & Kar, D. M. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328332572241219102122 · Cited by 5 · see citing works

Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach

Chowdhury, M., Chaudhary, N. R., Kaur, P., Goyal, A., & Sahu, S. K. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265267536231121095634 · Cited by 5 · see citing works

The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review

Carrossa, G., Misenti, V., Faggin, S., Giron, M. C., & Antonini, A. (2025) · Biomedicines · doi:10.3390/biomedicines13071769 · Cited by 5 · see citing works

The Emerging Role of the Brain–Gut Axis in Amyotrophic Lateral Sclerosis: Pathogenesis, Mechanisms, and Therapeutic Perspectives

Yang, E. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178419 · Cited by 4 · see citing works

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2 · see citing works

Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)

Kumar, R., & Kumar, R. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.004 · Cited by 2 · see citing works

Gut-brain axis modulation in remote rehabilitation of Parkinson’s disease: reconstructing the fecal metabolome and nigral network connectivity

Jin, Y., Wang, H., & Song, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1644490 · Cited by 1 · see citing works

Gut microbiota in regulation of neuromuscular coordination

Roy, S., Chakraborty, B., & Choudhury, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00024-6 · Cited by 1 · see citing works

Prebiotics/synbiotics as natural alternatives for brain development and aging – focus on nutrigenomic and direct effects: a systematic review

Gonçalves, L. V. P., Holanda, P. F. D. G., Cabral, A. V. D. S., Nunes, R. G. D. S., Lira, Y. V. D. S., Costa, M. R., Mendonça, I. P., de lima, A. A., de Oliveira, Ê. A. G., Peixoto, C. A., et al. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2649604 · Cited by 1 · see citing works

Dynamic Modulation of the Gut Microbiome in Neurodegenerative Diseases: Mechanisms, Therapeutic Potential, and Clinical Perspective

Devi, S., Debnath, N., Yadav, P., Satyavolu, S., Yadav, A. K., & Tyagi, N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70165 · Cited by 1 · see citing works

Parkinson’s disease and inflammatory bowel disease: exploring the connection between the two

Zhou, X., Zhang, X., Liang, H., & Bi, Y. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2026.01 · Cited by 1 · see citing works

Exploring the Interplay Between Gut Microflora and Parkinson’s

Swathi, M., Hazra, A., Dhanu, A. S., & Basalingappa, K. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_15

Gut Microbiota Modulation in Parkinson’s Disease: Exploring Phytotherapy, Pharmacotherapy, and Precision Interventions

Olalekan, S. O., Okwute, P. G., Osonuga, I. O., Mofolorunso, A. M., Adegbesan, B. O., Ezima, E. N., & Oluwatunase, G. O. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009908

Gut microbiome related therapeutics and dietary supplements

Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., & HariKrishnaReddy, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29932-2.00008-6

Parkinson’s Disease and the Microbiome: A New Frontier for Early Diagnosis

Chakkittukandiyil, A., & Sajini, D. V. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_4

Food-derived probiotics across genera for neurodegenerative diseases: Mechanistic insights and translational challenges

Zi, Y., Zhang, J., Lu, C., Pan, B., Zhao, X., & Xiao, X. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109395

Bidirectional mendelian randomization links circulating inflammation and gut microbiota to synucleinopathies, validated by probiotic modulation in a Parkinson’s disease mouse model

Zheng, X., Li, L., Huang, Z., & Zhou, L. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.06.001

Probiotics and Plant Extracts in the Gut–Brain Axis: Mechanisms, Interactions, and Clinical Perspectives

Sattar, Z., & Asili, J. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11152-1

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

Cuervo-Zanatta, D., Balasubramanian, H. B., Pasokh, A., & Zille, M. (2026) · FEBS Letters · doi:10.1002/1873-3468.70412

The gut microbiota-short-chain fatty acid-inflammation axis in Parkinson's disease motor dysfunction: mechanisms and future of dietary interventions

Wang, W., Sun, W., Ma, L., Xu, M., & Dong, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1889517

Modulation of the Gut Microbiota by Prebiotics, Probiotics, and Psychobiotics and Its Impact on the Gut Microbiota–Brain Axis: A Systematic Review

Revelo, S., & Anchundia, M. (2026) · Biology · doi:10.3390/biology15181598

Gut Microbiota Modulation in CNS Disorders: Therapeutic Strategies and Implications for Drug Efficacy

Ahmed, L. A., & Al‐Massri, K. F. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06192-1

Gut Microbiome Species Levilactobacillus brevis Protects Dopaminergic Neurons from α-Synuclein Toxicity In Vivo

Braun, N. J., & Mor, D. E. (2026) · Brain Sciences · doi:10.3390/brainsci16111141

Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model

Dong, X.-L., Wang, X., Liu, F., Liu, X., Du, Z.-R., Li, R. W., Xue, C.-H., Wong, K.-H., Wong, W.-T., Zhao, Q., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.180 · Cited by 75 · see citing works

Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson’s disease: results from an open label single-arm study

Andreozzi, V., Cuoco, S., Balestrieri, M., Fierro, F., Ferrara, N., Erro, R., Filippo, M. D., Barbella, G., Memoli, M. C., Silvestri, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74400-w · Cited by 42 · see citing works

Synergistic Effects of Plant Polysaccharides and Probiotics: A Novel Dietary Approach for Parkinson’s Disease Intervention

Jin, Y. H., Wang, L., Lin, R., He, J., Liu, D., Liu, Y., & Deng, Y. (2026) · Pharmaceuticals · doi:10.3390/ph19010157 · Cited by 4 · see citing works

A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease

Aktaş, B., Aslım, B., & Özdemir, D. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-65061-w · Cited by 37 · see citing works

Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism

Cuevas-Carbonell, S. G., Vásquez-Celaya, L., García-López, D., Granados-Patrón, D., García‐Miss, M. D. R., Álvarez-Cervera, F. J., Mut-Martı́n, M., Parra, I., Mendieta, L., Salgado, H., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.004 · Cited by 17 · see citing works